Ornithine Decarboxylase MRNA is Stabilized in an MTORC1-dependent Manner in Ras-transformed Cells

Overview

Journal Biochem J

Specialty Biochemistry

Date 2011 Nov 11

PMID 22070140

Citations 23

Authors

Sofia Origanti

Shannon L Nowotarski

Theresa D Carr

Suzanne Sass-Kuhn

Lan Xiao

Jian-Ying Wang

Lisa M Shantz

Affiliations

Soon will be listed here.

Abstract

Upon Ras activation, ODC (ornithine decarboxylase) is markedly induced, and numerous studies suggest that ODC expression is controlled by Ras effector pathways. ODC is therefore a potential target in the treatment and prevention of Ras-driven tumours. In the present study we compared ODC mRNA translation profiles and stability in normal and Ras12V-transformed RIE-1 (rat intestinal epithelial) cells. While translation initiation of ODC increased modestly in Ras12V cells, ODC mRNA was stabilized 8-fold. Treatment with the specific mTORC1 [mTOR (mammalian target of rapamycin) complex 1] inhibitor rapamycin or siRNA (small interfering RNA) knockdown of mTOR destabilized the ODC mRNA, but rapamycin had only a minor effect on ODC translation initiation. Inhibition of mTORC1 also reduced the association of the mRNA-binding protein HuR with the ODC transcript. We have shown previously that HuR binding to the ODC 3'UTR (untranslated region) results in significant stabilization of the ODC mRNA, which contains several AU-rich regions within its 3'UTR that may act as regulatory sequences. Analysis of ODC 3'UTR deletion constructs suggests that cis-acting elements between base 1969 and base 2141 of the ODC mRNA act to stabilize the ODC transcript. These experiments thus define a novel mechanism of ODC synthesis control. Regulation of ODC mRNA decay could be an important means of limiting polyamine accumulation and subsequent tumour development.

Citing Articles

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance.

Kharouf N, Flanagan T, Alamodi A, Al Hmada Y, Hassan S, Shalaby H Cells. 2024; 13(3.

PMID: 38334632 PMC: 10854812. DOI: 10.3390/cells13030240.

Amino acid metabolism in tumor biology and therapy.

Chen J, Cui L, Lu S, Xu S Cell Death Dis. 2024; 15(1):42.

PMID: 38218942 PMC: 10787762. DOI: 10.1038/s41419-024-06435-w.

Dynamic states of eIF6 and SDS variants modulate interactions with uL14 of the 60S ribosomal subunit.

Elliff J, Biswas A, Roshan P, Kuppa S, Patterson A, Mattice J Nucleic Acids Res. 2023; 51(4):1803-1822.

PMID: 36651285 PMC: 9976893. DOI: 10.1093/nar/gkac1266.

mTORC1 beyond anabolic metabolism: Regulation of cell death.

Zhu J, Wang H, Jiang X J Cell Biol. 2022; 221(12).

PMID: 36282248 PMC: 9606688. DOI: 10.1083/jcb.202208103.

Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling.

Shen H, Huang F, Zhang X, Ojo O, Li Y, Trummell H Nat Commun. 2022; 13(1):5013.

PMID: 36008408 PMC: 9411168. DOI: 10.1038/s41467-022-32754-7.

References

Suswam E, Nabors L, Huang Y, Yang X, King P . IL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR. Int J Cancer. 2004; 113(6):911-9. DOI: 10.1002/ijc.20675. View

Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Salmena L, Alimonti A . Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer. J Clin Invest. 2008; 118(9):3065-74. PMC: 2518073. DOI: 10.1172/JCI34739. View

Manzella J, Blackshear P . Specific protein binding to a conserved region of the ornithine decarboxylase mRNA 5'-untranslated region. J Biol Chem. 1992; 267(10):7077-82. View

Nowotarski S, Shantz L . Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model. J Biol Chem. 2010; 285(41):31885-94. PMC: 2951260. DOI: 10.1074/jbc.M110.148767. View

Foat B, Houshmandi S, Olivas W, Bussemaker H . Profiling condition-specific, genome-wide regulation of mRNA stability in yeast. Proc Natl Acad Sci U S A. 2005; 102(49):17675-80. PMC: 1295595. DOI: 10.1073/pnas.0503803102. View

Mazan-Mamczarz K, Galban S, Lopez de Silanes I, Martindale J, Atasoy U, Keene J . RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci U S A. 2003; 100(14):8354-9. PMC: 166233. DOI: 10.1073/pnas.1432104100. View

Tong X, Van Dross R, Abu-Yousif A, Morrison A, Pelling J . Apigenin prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition. Mol Cell Biol. 2006; 27(1):283-96. PMC: 1800648. DOI: 10.1128/MCB.01282-06. View

Liu L, Guo X, Rao J, Zou T, Marasa B, Chen J . Polyamine-modulated c-Myc expression in normal intestinal epithelial cells regulates p21Cip1 transcription through a proximal promoter region. Biochem J. 2006; 398(2):257-67. PMC: 1550304. DOI: 10.1042/BJ20060217. View

Rao J, Liu L, Zou T, Marasa B, Boneva D, Wang S . Polyamines are required for phospholipase C-gamma1 expression promoting intestinal epithelial restitution after wounding. Am J Physiol Gastrointest Liver Physiol. 2006; 292(1):G335-43. DOI: 10.1152/ajpgi.00282.2006. View

10.

Topisirovic I, Siddiqui N, Orolicki S, Skrabanek L, Tremblay M, Hoang T . Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer. Mol Cell Biol. 2008; 29(5):1152-62. PMC: 2643828. DOI: 10.1128/MCB.01532-08. View

11.

Katsanou V, Papadaki O, Milatos S, Blackshear P, Anderson P, Kollias G . HuR as a negative posttranscriptional modulator in inflammation. Mol Cell. 2005; 19(6):777-89. DOI: 10.1016/j.molcel.2005.08.007. View

12.

Gerner E, Meyskens Jr F . Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004; 4(10):781-92. DOI: 10.1038/nrc1454. View

13.

Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale J, Gorospe M . Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 2004; 23(15):3092-102. PMC: 514922. DOI: 10.1038/sj.emboj.7600305. View

14.

Origanti S, Shantz L . Ras transformation of RIE-1 cells activates cap-independent translation of ornithine decarboxylase: regulation by the Raf/MEK/ERK and phosphatidylinositol 3-kinase pathways. Cancer Res. 2007; 67(10):4834-42. DOI: 10.1158/0008-5472.CAN-06-4627. View

15.

Ito K, Kashiwagi K, Watanabe S, Kameji T, Hayashi S, Igarashi K . Influence of the 5'-untranslated region of ornithine decarboxylase mRNA and spermidine on ornithine decarboxylase synthesis. J Biol Chem. 1990; 265(22):13036-41. View

16.

Repasky G, Chenette E, Der C . Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?. Trends Cell Biol. 2004; 14(11):639-47. DOI: 10.1016/j.tcb.2004.09.014. View

17.

Lai W, Parker J, Grissom S, Stumpo D, Blackshear P . Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol. 2006; 26(24):9196-208. PMC: 1698545. DOI: 10.1128/MCB.00945-06. View

18.

Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg M, Hall A . Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol. 2004; 6(11):1122-8. DOI: 10.1038/ncb1183. View

19.

Marderosian M, Sharma A, Funk A, Vartanian R, Masri J, Jo O . Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene. 2006; 25(47):6277-90. DOI: 10.1038/sj.onc.1209645. View

20.

Garneau N, Wilusz J, Wilusz C . The highways and byways of mRNA decay. Nat Rev Mol Cell Biol. 2007; 8(2):113-26. DOI: 10.1038/nrm2104. View